Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Bermudez (Marseille, France), B. Coulon (Marseille, France), Y. Trigui (Marseille, France), C. Gomez (Marseille, France), J. Mege (Marseille, France), N. Bardin (Marseille, France), M. Reynaud-Gaubert (Marseille, France). Lung involvement associated with anti-NXP2 autoantibodies: a monocentre observational French study. 3021

Member's Comments

No comment yet.

Related content which might interest you: Protocol for the EARCO Registry: a pan-European observational study in patients with a1-antitrypsin deficiency Source: ERJ Open Res, 6 (1) 00181-2019; 10.1183/23120541.00181-2019 Year: 2020 Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020 Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study). Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Assessment of the association between asthma and malignancy: a population-based retrospective matched cohort study Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases Year: 2009 Late Breaking Abstract - A composite serum biomarker index for the diagnosis of systemic sclerosis associated interstitial lung disease: a multicentre, observational, cohort study Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes Year: 2021 Clinical Assessment of Glycopyrronium in COPD phenotypes and ACOS: Prospective, case control, observational study Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Plasma levels of acute phase proteins in patients from the multicenter longitudinal French Cohort in Lung Transplantation (COLT): a pilot study Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020 Health resource utilisation due to IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 Clinical course of IPF Italian patients during 12-month of observation: results from the FIBRONET observational study Source: International Congress 2019 – Interstitial lung disease registries Year: 2019 An Italian, observational, multicenter trial in female COPD patients: Preliminary data on the women reality in the MISTRAL study Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Validation of soluble mesothelin: design and preliminary results of a Belgian multicentric observational study Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools Year: 2009 The prevalence and diversity of fungi in respiratory samples of cystic fibrosis patients – a Dutch, nationwide, prospective, multicentre study Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study Source: ERJ Open Res, 5 (1) 00175-2018; 10.1183/23120541.00175-2018 Year: 2019 Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort Source: Eur Respir J, 57 (4) 2001160; 10.1183/13993003.01160-2020 Year: 2021 A multicentre cohort study on the association between common markers of asthma and the incidence of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 295s Year: 2006 A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 Variables associated with functional improvement in patients with interstitial lung disease and myositis related antibodies: Results from a multicentric Latin American study. Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Open label case-control study to assess Pidotimod efficacy in Non CF Bronchiectasis Disease: a pilot study Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017